News: Four stocks surge as DIAGENS Biotechnology makes its debut

Medical device manufacturer Hangzhou DIAGENS Biotechnology Co., Ltd. went public on Monday, with its stock price more than doubling on the first day, setting a record for the highest number of listings in a single day in the Hong Kong market. DIAGENS Biotechnology issued approximately 8 million shares at HKD 99 per share, raising a net amount of approximately HKD 720 million. The public offering was oversubscribed by 1,000 times, and the international placement was oversubscribed by 2.45 times. The stock price during the afternoon trading session was HKD 215, an increase of 117%, with a market capitalization of approximately HKD 19.1 billion. Revenue for the first three quarters of last year rose from HKD 19.6 million to nearly HKD 112 million, with losses narrowing to HKD 36.3 million